Liveyon Labs

Liveyon Labs was a U.S. regenerative medicine company focused on processing human umbilical cord blood-derived cellular products, including PURE and PURE PRO, for allogeneic use. The company worked alongside affiliated marketer/distributor Liveyon LLC to commercialize injectable stem cell-related products promoted for orthopedic and other serious conditions. FDA determined these products were unapproved biologic/drug products and cited the company for significant CGTP and CGMP deficiencies, including donor eligibility, aseptic processing, and environmental monitoring concerns. The business appears to be inactive and effectively closed following regulatory enforcement, product safety concerns, and related criminal proceedings involving company leadership. For a biotech analyst, this is best understood as a defunct commercial-stage regenerative medicine manufacturer/distributor rather than a conventional therapeutic developer with an active clinical pipeline.